An Economic Review of Compliance With Medication Therapy in the Treatment of Schizophrenia
Psychiatric Services2003Vol. 54(4), pp. 508–516
Citations Over TimeTop 10% of 2003 papers
Abstract
A definitive relationship exists between compliance and the economic costs of schizophrenia. Lower rates of compliance lead to higher costs of treating schizophrenia. However, the full implications are difficult to surmise from the literature because of inadequacies in the reporting of compliance rates and outcomes of treatment over time. The authors suggest collection of data on longer-term clinical outcomes as a means to improve future economic evaluations of schizophrenia treatments.
Related Papers
- → The Economic Costs Associated With Physical Inactivity and Obesity in Canada: An Update(2004)649 cited
- Economic burden of smoking: a systematic review of direct and indirect costs.(2016)
- → Economic Cost of Schizophrenia in a Nigerian Teaching Hospital(2018)18 cited
- Economic Burden of Schizophrenia: Based on Medical Insurance Database from Guangzhou(2014)
- The Economic Costs Of Anxiety In Spain(2006)